SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63365 356 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
62761The Rick Barry effect, ala MiMedx. Except in that case the corruption was real.ghettogoulash-8/3/2024
62760Doc, Thanks for the summary and sharing with the board. As a finance/accountiDavidoff28/3/2024
62759So just spoke to Matt for 90 minutes. Mostly went through the history of the costockdoc77128/3/2024
62758weather, short answer to your qs :"no". taken directly from Cassava pscorman118/3/2024
62757>> note that a confirmatory followup trial is NOT stipulated...the SPAsweatherproof18/3/2024
62756How does Remi prevent the DSMB from doing that? Doesn't the DSMB have unresweatherproof18/3/2024
62755SAVA Nov '21 10q: "End-of-Phase 2 (EOP2) Meeting with FDA In January scorman1-8/3/2024
62754I am caught up on early vs mild, vs moderate nomenclature. FDA guidance on earlscorman128/3/2024
62753Just texted you to set up a a timestockdoc7718/3/2024
62752Again, Stew, I'm just catching up with you guys on the SAVA-specific data. weatherproof58/3/2024
62751W/r to SAVA approval, IMHO I would like to promote a perspective of "positiscorman128/3/2024
62750Matt, Welcome. I have followed your twitter posts as well as comments on otheDavidoff28/3/2024
62749The shorts were very successful in getting the attention of the DOJ, NIH/ORI andMattNachtrab18/3/2024
62748Good morning Stockdoc. I caught up quick on some of the posts here. plhky3465 MattNachtrab28/3/2024
62747We gotta ways to go yet. My price target going into Rethink has always been $5B+ghettogoulash-8/3/2024
62746Doc Like many I have appreciated your thoughtful contributions over the years. ADavidoff38/2/2024
62745I read the tweets. I would like to talk to him, I sent you a private message.stockdoc77-8/2/2024
62744Haha Stockdocghettogoulash-8/2/2024
62743Therein lies the difference. The sava/avxl OLEs are "generating additional ghettogoulash-8/2/2024
62742Are you up for adopting….:). We can only hope that someone (Sava) gets us all hrodneyh07-8/2/2024
62741Any thoughts on whether the short term price action - exponential rise in SP - iOlecranon18/2/2024
62740Stockdoc: Matt Nachtrab is an individual who owns over 2 million shares of SAVAplhky346528/2/2024
62739the OLE is more than allowing patients who are doing well to continue. In many cscorman118/2/2024
62738I'm still having a hard time making sense of the meaning of the OLE. Can yostockdoc77-8/2/2024
62737For those interested in FDA's 2024 guidance re Alzheimers trials: fda.govweatherproof-8/2/2024
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News